Memorial Bahcelievler Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)2 trials
• Colorectal cancer1 trial
• Coronary artery disease1 trial
• Liver cirrhosis1 trial
• Lung cancer1 trial
• Melanoma1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial

Status

• Recruiting4 trials
• Active, not recruiting2 trials

Lead sponsor

• Boehringer Ingelheim2 trials
• Amgen1 trial
• Biruni University1 trial
• Elixir Medical Corporation1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Aerobic Exercise and Guided Imagery in Low Anterior Resection Syndrome

  NCT07732894· Biruni University· Source

  Contact: burçin özyürek

• Recruiting

  LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

  NCT06632457· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Recruiting

  DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

  NCT06074549· Elixir Medical Corporation· Source

  Contact: Omer Goktekin, MD

• Active, not recruiting

  A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

  NCT06054555· Phase 3· Amgen· Source

• Active, not recruiting

  A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT05785767· Phase 2/3· Regeneron Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)2 recruiting
• Colorectal cancer1 recruiting
• Coronary artery disease1 recruiting
• Liver cirrhosis1 recruiting